ExploreWatchlistsPricing
  1. JP-listed companies
  2. TSUMURA & CO.
  3. Financials
  4. Cash from financing

TSUMURA & CO. (4540)

Market cap
¥290.1B
P/E ratio
11.8x
Tsumura manufactures prescription and over-the-counter medicines, specializing in herbal extract powders and raw medicinal herbs across Japan, China, Laos, and the US.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from financing (Million JPY)YoY (%)
Mar 31, 2025-19,871+349.88%
Mar 31, 2024-4,417-118.09%
Mar 31, 202324,423-398.53%
Mar 31, 2022-8,181-21.53%
Mar 31, 2021-10,425-246.60%
Mar 31, 20207,111-138.38%
Mar 31, 2019-18,528-136.83%
Mar 31, 201850,305-625.54%
Mar 31, 2017-9,572+107.73%
Mar 31, 2016-4,608-144.27%
Mar 31, 201510,408

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat